T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.39B |
| 2 |
PayPal
PYPL
|
+$741M |
| 3 |
Fifth Third Bancorp
FITB
|
+$702M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$664M |
| 5 |
Morgan Stanley
MS
|
+$616M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$5.86B |
| 2 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$911M |
| 3 |
Estee Lauder
EL
|
+$831M |
| 4 |
GE Aerospace
GE
|
+$827M |
| 5 |
Honeywell
HON
|
+$825M |
Sector Composition
| 1 | Healthcare | 22.49% |
| 2 | Consumer Discretionary | 15.06% |
| 3 | Financials | 13.94% |
| 4 | Technology | 11.82% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
BioCryst Pharmaceuticals
BCRX
$1.66B
| $7.74M | ﹤0.01% |
750,100
-356,989
| -32% | -$3.68M |
|
1327
Gray Television
GTN
$598M
| $7.74M | ﹤0.01% |
474,700
+456,500
| +2,508% | +$7.44M |
|
1328
AutoNation
AN
$8.37B
| $7.72M | ﹤0.01% |
129,311
| – | – |
|
1329
IQVIA
IQV
$31.8B
| $7.68M | ﹤0.01% |
111,866
+20,666
| +23% | +$1.42M |
|
1330
Garmin
GRMN
$45.8B
| $7.68M | ﹤0.01% |
206,590
-2,400
| -1% | -$89.2K |
|
|
DXYN
1331
DELISTED
Dixie Group Inc
DXYN
| $7.64M | ﹤0.01% |
1,461,520
-21,200
| -1% | -$111K |
|
|
HBMD
1332
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $7.64M | ﹤0.01% |
578,310
-2,550
| -0.4% | -$33.7K |
|
1333
iShares MSCI India ETF
INDA
$9.38B
| $7.61M | ﹤0.01% |
276,200
+25,500
| +10% | +$702K |
|
|
I
1334
DELISTED
INTELSAT S. A.
I
| $7.6M | ﹤0.01% |
1,827,370
-125,100
| -6% | -$520K |
|
1335
Copart
CPRT
$46.8B
| $7.6M | ﹤0.01% |
1,598,752
-2,848
| -0.2% | -$13.5K |
|
1336
Transocean
RIG
$3.11B
| $7.58M | ﹤0.01% |
612,280
-18,500
| -3% | -$229K |
|
|
SNMX
1337
DELISTED
Senomyx, Inc.
SNMX
| $7.58M | ﹤0.01% |
2,010,585
+67,170
| +3% | +$253K |
|
1338
Carlyle Group
CG
$24.1B
| $7.56M | ﹤0.01% |
484,000
+2,300
| +0.5% | +$35.9K |
|
1339
Hain Celestial
HAIN
$194M
| $7.5M | ﹤0.01% |
185,648
+68,705
| +59% | +$2.77M |
|
|
DF
1340
DELISTED
Dean Foods Company
DF
| $7.48M | ﹤0.01% |
435,928
-675,860
| -61% | -$11.6M |
|
1341
Designer Brands
DBI
$225M
| $7.47M | ﹤0.01% |
313,217
-43,745
| -12% | -$1.04M |
|
1342
Core Laboratories
CLB
$581M
| $7.47M | ﹤0.01% |
68,700
-11,105
| -14% | -$1.21M |
|
|
DISCA
1343
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $7.4M | ﹤0.01% |
277,320
-10
| -0% | -$267 |
|
1344
Howard Hughes
HHH
$4.84B
| $7.39M | ﹤0.01% |
68,506
+2,603
| +4% | +$281K |
|
|
CSRA
1345
DELISTED
CSRA Inc.
CSRA
| $7.31M | ﹤0.01% |
+243,804
| New | +$7.31M |
|
|
ESL
1346
DELISTED
Esterline Technologies
ESL
| $7.31M | ﹤0.01% |
90,270
-1,020
| -1% | -$82.6K |
|
|
WFC.WS
1347
DELISTED
Wells Fargo & Company Ws
WFC.WS
| $7.28M | ﹤0.01% |
355,275
| – | – |
|
1348
Galicia Financial Group
GGAL
$4.81B
| $7.28M | ﹤0.01% |
268,780
+8,590
| +3% | +$233K |
|
1349
Nektar Therapeutics
NKTR
$926M
| $7.2M | ﹤0.01% |
28,480
+3,267
| +13% | +$826K |
|
|
ACOR
1350
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $7.16M | ﹤0.01% |
1,395
+327
| +31% | +$1.68M |
|